Treating periodontal disease may reduce prostate inflammation
the ONA take:
According to a new report published in the journal Dentistry, researchers from Case Western Reserve University School of Dental Medicine and the Departments of Urology and Pathology at University Hospitals Case Medical Center in Cleveland, Ohio, have found that treating gum disease reduced symptoms of prostate inflammation.
For the study, researchers enrolled 27 men with confirmed inflammation of the prostate gland and elevated prostate specific antigen (PSA) levels.
All of the men also had moderate to severe gum disease. Of the 27 participants, 21 had no or mild inflammation, 15 had biopsy-confirmed malignancies, and two had inflammation and malignancy. All were then treated for periodontal disease.
Results showed that despite receiving no prostate treatment, 21 of the 27 participants had decreased PSA levels. Researchers found that those with the highest levels of prostate inflammation benefited the most from gum disease treatment.
"This study shows that if we treat the gum disease, it can improve the symptoms of prostatitis and the quality of life for those who have the disease," said Nabil Bissada, chair of Case Western Reserve's Department of Periodontics and the new study's corresponding author.
Treating gum disease reduced symptoms of prostate inflammation.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Immunotherapy and the Future of Prostate Cancer Treatment
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Use of Checkpoint Inhibitors in Urothelial Carcinoma
- Chemo + Radiotherapy Efficacious in Muscle-invasive Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Colorectal Cancer Risk Higher With Poor Metabolic Health vs Increased Weight
- Best Approach to Infection and Tumor Treatment: Contain or Eliminate?
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|